As Chief Medical Officer Dr. James Kyle Bryan is responsible for strategic global medical and scientific leadership for our company, leading the Medical, Safety, Feasibility, Oncology Strategy, and Global Strategic Delivery teams. Kyle draws on his knowledge of drug development and his clinical experience to advise and assist our customers.
Focused on drug discovery and development in the biotechnology and pharmaceutical industries for more than 25 years, Kyle offers a unique perspective on navigating medical and safety challenges and needs within clinical trials. He has worked in biotechnology companies as well as for clinical research organizations.
Kyle is board-certified in hematology and medical oncology and remains actively engaged in clinical care as a clinical faculty member at the University of Washington Medical Center. This work allows him to better understand the current needs and wants of patients to factor into his guidance to our teams.
Kyle earned a bachelor’s degree in Biochemistry and medical degree from Louisiana State University and completed a fellowship in hematology and oncology at the University of Washington. He resides in Seattle where he is the father of two teenagers and an advocate for adoption and foster care.